chr9-78297253-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_058179.4(PSAT1):āc.43G>Cā(p.Ala15Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000687 in 1,600,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A15T) has been classified as Uncertain significance.
Frequency
Consequence
NM_058179.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PSAT1 | NM_058179.4 | c.43G>C | p.Ala15Pro | missense_variant | 1/9 | ENST00000376588.4 | |
PSAT1 | NM_021154.5 | c.43G>C | p.Ala15Pro | missense_variant | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PSAT1 | ENST00000376588.4 | c.43G>C | p.Ala15Pro | missense_variant | 1/9 | 1 | NM_058179.4 | P1 | |
PSAT1 | ENST00000347159.6 | c.43G>C | p.Ala15Pro | missense_variant | 1/8 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000485 AC: 11AN: 226894Hom.: 0 AF XY: 0.0000481 AC XY: 6AN XY: 124620
GnomAD4 exome AF: 0.00000690 AC: 10AN: 1448430Hom.: 0 Cov.: 36 AF XY: 0.00000555 AC XY: 4AN XY: 720608
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74374
ClinVar
Submissions by phenotype
PSAT deficiency Pathogenic:1Uncertain:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 08, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Neu-Laxova syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jul 27, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 15 of the PSAT1 protein (p.Ala15Pro). This variant is present in population databases (rs774962204, gnomAD 0.05%). This missense change has been observed in individual(s) with clinical features of PSAT1-related conditions (PMID: 34089226). ClinVar contains an entry for this variant (Variation ID: 367451). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on PSAT1 function (PMID: 32077105). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Microcephaly Uncertain:1
Uncertain significance, no assertion criteria provided | research | Department of Pediatrics, Samsung Medical Center, Samsung Medical Center | - | - - |
not provided Other:1
not provided, no classification provided | in vivo;research | Dudley Research Group, Pacific Northwest Research Institute | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at